COVID-19 Update | July 31, 2020

COVID-19 News

COVID-19 Update | July 31, 2020

July 31, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of July 31, 2020. Notable advancements include:

  • Moderna announced that its COVID-19 vaccine is moving into the final phase of testing with a study of 30,000 participants.
  • Pfizer’s COVID-19 vaccine is moving into the third phase of testing at 120 clinical sites worldwide.
  • Merck has scheduled large-scale studies for its oral coronavirus treatment in collaboration with Ridgeback Biotherapeutics as early as September.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new CABiotech.org

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or patty.cooper@cabiotech.org.